United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$255Mraised across 3 rounds since 2017, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Perceptive Advisors
Janus Henderson Investors
Cormorant Asset Management
Redmile Group
RTW Investments LLCSource recorded
Janus Henderson InvestorsRedmile Group
Alexandria Real Estate Equities
Cormorant Capital
Perceptive VenturesReported by FinSMEsSEC filing: $90M sold, first sale Oct 2018
From the SEC filings it signed: 8 on the team.
On the board, as filediArthur A. LevinArthur W. TzianabosSamuel W. HallSeth L. Harrison
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Stoke Therapeutics's investors include Janus Henderson Investors, Redmile Group, RA Capital Management, Perceptive Advisors and Cormorant Asset Management, and 8 more on record.
Stoke Therapeutics has raised $255M across 3 rounds since 2017.
Stoke Therapeutics's most recent round was an Undisclosed round of $125M in Mar 2024.
Its most recent round, $125M in Mar 2024, is also its largest on record.
Stoke Therapeutics's first round on record, in Jan 2017, was backed by Apple Tree Partners.
Stoke Therapeutics's latest named round is an Undisclosed round, in Mar 2024.
Stoke Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
